Sentinel lenf nodu biyopsisi donrası her iki memede metilen mavisine karşı gelişen alerjik reaksiyon

Sentinel lenf nodu biyopsisi SLNB meme kanserinin evrelemesinde standart yaklaşımdır. Mavi boya, lenfosintigrafi ve sentimag SLNB için tanımlanmış önemli metotlardır. Diğer iki yöntemle kıyaslandığında mavi boya kullanımı daha yaygın ve daha ekonomiktir. Patent mavisi, izosülfan mavisi ve metilen mavisi sentinel lenf nodunun SLN tespiti için kullanılan üç önemli temel boyalardır. Metilen mavisi diğer mavi boyalara göre çok daha kolay ulaşılabilir ve daha ucuzdur. Metilen mavisinin meme kanseri ameliyatı esnasında parankime enjekte edilmesi güvenlidir ancak bazı olgularda alerjik reaksiyonlar bildirilmiştir. Bu olguda 83 yaşında, sağ taraf meme kanserli, kadın hasta sunulmuştur. Hasta segmental mastektomi ve SLNB ile tedavi edildi. SLNB için metilen mavisi kullanıldı. Ameliyattan sonra her iki memede eritem görüldü. Vaka takdiminin amacı metilen mavisine karşı gelişen bu nadir alerjik reaksiyonu sunmaktır.

Allergic reaction against methylene blue in both of the breasts after sentinel lymph node biopsy

The sentinel lymph node biopsy SLNB is the gold standard in staging of breast cancer. Blue dye, lymphoscintigraphy and sentimag are three main methods described for SLNB. Blue dye use for SLNB is more cost-effective when compared to other two methods. Patent blue, isosulfan blue and methylene blue are vital dyes, which are used to identify the sentinel lymph node SLN . Methylene blue is easily available and less expensive than other dyes. Injection of methylene blue into the parenchyma to identify SLN is safe during breast cancer operation, although in some cases allergic reactions have been reported. In this case a 83 years old female patient with right side breast cancer has presented. The patient was treated with partial mastectomy and SLNB. Methylene blue dye was used for SLNB. After operation erythema has seen in both of the breasts. The aim of the case report is to present this rare allergic reaction against methylene blue dye.

___

  • Giuliano AE, Kirgan DM, Guenther JM et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398
  • Mansel RE, Fallowfield L, Kissin M et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599- 609
  • Andreas Karakatsanis, Peer Michael Christiansen, Lone Fischer et al. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta- analysis of earlier studies. Breast Cancer Res Treat 2016;157:281–294
  • Pei-Sheng He, Feng Li, Guan-Hua Li et al. The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic review. BMC Cancer 2016;16:107
  • Regis Resende Paulinelli, Ruffo Freitas-Junior, Rosemar Macedo de Souza Rahal et al. A prospective randomized trial comparing patent blue and methylene blue fort he detection of the sentinel lymph node in breast cancer patients. Rev Assoc Med Bras 2017;63:118-123
  • Varghese P, Abdel-Rahman AT, Akberali S et al. Methylene blue dye: a safe and effective alternative for sentinel lymph node localization. Breas J. 2008;14:1-7 7.Thevarajah S, Huston TL, Simmons RM et al. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005;189:236-239
  • Kopp WL. Anaphylaxis from alphazurine 2G during lymphography. JAMA 1966;198:668-669
  • Seok Seon Kang, Boo-Kyun Han, Eun Young Ko et al. Methylene blue dye-related changes in the breast after sentinel lymph node localization. J Ultrasound Med 2011;30:1711-1721
  • Giuliano AE, Jones RC, Brennan M et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345-2350
  • Corinne Bezu, Charles Countant, Anne Salengro et al. Anaphylactic response to blue dye during sentinel lymph node biopsy. Surgical Oncology 2011;20:55-59 12.Barthelmes L, Goyal A, Newcombe RG et al. Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience. Eur J Surg Oncol; 2010;36:399- 403